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activity of fluoroquinolones is correlated to the area under the
concentration curve (AUC) : MIC ratio; to the peak serum
level : minimal bactericidal concentration (MBC) ratio; and to
the time of exposure at concentrations greater than the MIC
[1]. Thus, there are strong arguments in favor of a potent
bactericidal activity of fluoroquinolones in Aa endocarditis [1]:
the very high serum concentration : MIC ratio observed in
these observations [2]; in our report, the relatively long half-
life of ofloxacin (about 8 h) [3]; a high concentration of fluoro-
quinolones in cardiac vegetations, as shown in experimental
endocarditis [1]. Otherwise, ciprofloxacin has been successfully
used to treat left-sided endocarditis due to Gram-negative
micro-organisms such as Salmonella enteritidis [4] and Yersinia
enterocolitica [5].
This new case report suggests the possibility of oral treatment
of endocarditis due to HACEK-organisms that are usually sen-
sitive to fluoroquinolones, such as Aa, Haemophilus sp., or
Eikenella. This drug regimen could be indicated as a follow-on
after 10–15 days duration of conventional intravenous treat-
ment if the patient presents no major valvular or cardiac dys-
function, and would allow an ambulatory follow-up after a
shortened initial hospitalization. Moreover, this drug regimen
may represent a valuable alternative treatment in case of b-
lactam intolerance.
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Recently, the Rakai study tested the hypothesis that community-
level control of sexually transmitted disease (STD) would result in
lower incidence of HIV-1 infection in comparison with control
communities [1]. This randomized, controlled, single-masked,
community-based trial of intensive STD control, via home-based
mass antibiotic treatment, took place in Rakai District, Uganda.
Ten community clusters were randomly assigned to intervention
or control groups. All consenting residents aged 15–59 years were
enrolled, visited in the home every 10 months, interviewed,
asked to provide biological samples for assessment of HIV-1
infection and STD, and were provided with mass treatment
(azithromycin, ciprofloxacin, metronidazole in the intervention
group, vitamins/anthelmintic drug in the control group).
However, no effect of the STD intervention was observed on
the incidence of HIV-1 infection. In the Rakai population, a
substantial proportion of HIV-1 acquisition appears to occur
independently of treatable STD cofactors. Untreated genital
infections such as genital herpes might overwhelm any effects
associated with treatment of classic STD. In the Rakai study,
serological testing for herpes simplex virus type 2 (HSV-2)
revealed a high prevalence of 31% in men and 61% in women.
Furthermore, 43% of self-reported genital ulcers were for HSV-
2 by multiplex polymerase chain reaction (PCR). Asymptomatic
genital shedding of HSV-2 may be a cofactor of heterosexual
transmissionofHIV that was not investigated in the studypopulation
We have evaluated the frequency of asymptomatic genital
shedding of HSV-2 in women of childbearing-aged who were
attending the National Reference Center for Sexually Trans-
mitted Diseases of Bangui, the capital of the Central African
Republic. In this population, 80% of women were seropositive
for HSV-2 using a type-specific enzyme-linked immuno-
sorbent assay [2]. Cervicovaginal lavage samples were pro-
spectively obtained from 280 women without clinical evidence
of genital ulcers, of whom 78 (27.8%) were seropositive for
HIV-1. HSV-2 DNA sequences were detected in the acellular
part of cervicovaginal secretions by PCR followed by DNA
enzyme immunoassay hybridization. Seventy-nine (28.2%)
women were shedding HSV-2. The HSV-2 shedding was
nearly two-fold higher in HIV-infected women [41.0% (32 of
78)] in comparison with HIV-negative women [23.3% (47
of 202)] (P = 0.0001). These findings clearly demonstrate that
asymptomatic genital carriage of HSV-2 may be very common
in an African population that is highly seropositive for HSV-2.
Co-infection by HIV and HSV-2 increases the rate of
asymptomatic genital shedding of HSV-2. Asymptomatic rep-
lication of HSV-2 in the genital tract of HIV-infected women
may increase the genital replication of HIV [3,4], resulting in
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both increased infectivity and female-to-male transmission of
HIV. Thus, bidirectional interaction between HIV and HSV-
2 may act synergistically in a vicious circle, each infection
enhancing the genital replication of the other. In a population
such as the Rakai population, where seroprevalence for HSV-
2 is high, symptomatic HSV-2 infection (genital ulcer) as well
as asymptomatic genital HSV-2 shedding may constitute major
cofactors for HIV transmission. In areas of high prevalence
for HSV-2 infection, intervention measures should include: (i)
revision of current guidelines for genital ulcer management to
include antiviral treatment for herpes, and (ii) HSV-2 screening
and suppressive antiviral therapy among HIV and HSV-2 co-
infected individuals (possibly difficult to realize in Africa).
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